查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1515450

PARP 抑制剂生物标记市场，按产品、服务、应用和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

PARP Inhibitor Biomarkers Market, By Product, By Services, By Application, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年 PARP 抑制剂生物标记市场规模为 9.158 亿美元，2024 年至 2032 年复合年增长率为 8.80%。

PARP 抑制剂生物标记市场-市场动态

癌症管理和治疗成本上升推动市场成长

管理和治疗成本的不断增长预计将支持市场扩张。例如，《柳叶刀地区卫生》杂誌 2022 年 10 月发表的一篇期刊论文报道了印度寻求全面结直肠癌治疗的患者的治疗减员和灾难性费用。在纳入的 226 名患者中，有 4 名患者失访，20 名患者在接受治疗计划后六个月内去世。大肠直肠癌的治疗费用平均为 407,508 印度卢比（印度卢比/5,340 美元）。患者的 PARP（中位数价值 330,277 印度卢比/4328 美元）是总费用的最大贡献者。

PARP 抑制剂生物标记市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 8.80% 左右的复合年增长率成长

根据服务细分，预计 BRCA 1 和 2 测试类别将在 2023 年显示最大的市场份额

基于应用细分，2023年乳癌类别为主导类型

按地区划分，北美是 2023 年的主要收入来源

PARP 抑制剂生物标记市场 - 細項分析：

全球 PARP 抑制剂生物标记市场根据产品、服务、应用和区域进行细分。

市场依产品分为两类：试剂盒和检测。试剂盒类别在市场上占据主导地位，因为这些试剂盒用于测试和诊断与基因突变和变化相关的疾病。与遗传性 DNA 突变相关的最常见疾病之一是乳癌。为了满足对准确、高效诊断不断增长的需求，市场主要参与者不断致力于开发新的解决方案。 Myriad Genetics, Inc. 的 myChoice CDx 是经 FDA 批准的一项测试，用于确定患有同源重组缺陷 (HRD) 状态的晚期卵巢癌个体。

根据应用，市场分为以下几类：乳癌、卵巢癌和其他。肿瘤学类别在市场中占据主导地位，并可能在预测期内保持其主导地位。与 BRCA1 或 BRCA2 基因突变引起的基因改变相关的乳癌发生率的增加被认为是该片段扩张的原因。世界卫生组织 2023 年 2 月的文章指出，预计到 2040 年，将有 250 万人受到乳癌的影响。各国。儘管如此，存活率差异很大，大部分死亡发生在低收入和中等收入国家。过去三十年来，高收入国家的乳癌死亡率显着下降，而低收入和中等收入国家则没有类似的下降。

PARP 抑制剂生物标记市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

在预测期内，北美预计将在 PARP 抑制剂生物标记全球市场中占据最大份额。这一高比例可归因于癌症治疗成本的上升、基因组技术的进步以及癌症盛行率的上升。美国癌症协会的一篇文章预计，到 2022 年，美国将有约 609,360 人因癌症死亡，新诊断癌症病例将超过 190 万例。因此，随着癌症变得越来越普遍，越来越多的患者使用基因测试来识别 PARP 抑制剂治疗的潜在候选者，这推高了生物标记测试的成本。

此外，由于包括 Thermo Fisher Scientific, Inc.、QIAGEN 和 Illumina 在内的重要区域和国家市场参与者的存在，预计亚太地区 PARP 抑制剂生物标记市场将以全球最快的速度扩张。成长也将受到以下因素的推动：政府改善医疗基础设施的倡议、人均收入的增加导致更多地采用诊断和治疗产品，以及整个地区对PARP 抑制剂生物标记技术的投资大幅增加。在预测期内，由于具有新先进功能的智慧型手机的使用不断增加，中国、日本和印度等新兴国家预计将推动市场扩张。

PARP 抑制剂生物标记市场-竞争格局：

该领域的领导企业包括 Ambry Genetics、Myriad Genetics, Inc.、Thermo Fisher Scientific, Inc. 和 Illumina, Inc.。为了应对激烈的竞争，这些公司转向了各种策略，包括合作伙伴关係、併购以及创造新产品。

最近的发展：

2024 年 2 月：基因检测与精准医疗新创公司 Myriad Genetics, Inc. 成功收购了 Intermountain Health 旗下 Intermountain Precision Genomics (IPG) 实验室集团的多项资产。此次收购包括他位于犹他州圣乔治的 CLIA 认证实验室，以及精密流体测试和精密肿瘤学测试。

2024 年 1 月：基因检测和精准医疗製造商 Myriad Genetics, Inc. 已表示支持 ASCO 和 SSO 关于乳癌患者种系检测的指南。该公司强调 ASCO-SSO 指南的更新是遗传学融入患者治疗的重要一步。

2023 年 1 月：寻找前列腺癌对 PARP 药物抗药性的新指标在很大程度上是透过 CRISPR 技术实现的。研究人员利用全基因组 CRISPR 敲除筛选来研究不同的基因改变如何影响 PARP 药物的有效性。 MMS22L 基因的鑑定是这些研究中值得注意的发现，该基因被删除后可显着提高对 PARP 抑制剂的敏感性。

目录

第 1 章：PARP 抑制剂生物标记市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • PARP 抑制剂生物标记市场片段（按产品）
    • PARP 抑制剂生物标记市场片段（按服务）
    • PARP 抑制剂生物标记市场片段（按应用）
    • PARP 抑制剂生物标记市场片段（按国家/地区）
    • PARP 抑制剂生物标记市场片段（按地区）
  • 竞争洞察

第 3 章：PARP 抑制剂生物标记主要市场趋势

  • PARP 抑制剂生物标记市场驱动因素
    • 市场驱动因素的影响分析
  • PARP 抑制剂生物标记市场限制
    • 市场限制影响分析
  • PARP 抑制剂生物标记市场机会
  • PARP 抑制剂生物标记市场未来趋势

第 4 章：PARP 抑制剂生物标记产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：PARP 抑制剂生物标记市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：PARP 抑制剂生物标记市场格局

  • 2023 年 PARP 抑制剂生物标记市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：PARP 抑制剂生物标记市场 - 按产品

  • 概述
    • 按产品分類的细分市场占有率分析
    • 套件
    • 化验

第 8 章：PARP 抑制剂生物标记市场 - 按服务

  • 概述
    • 按服务分類的细分市场占有率分析
    • BRCA 1 和 2 测试
    • 人力资源开发测试
    • HRR测试
    • 其他的

第 9 章：PARP 抑制剂生物标记市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 乳癌
    • 卵巢癌
    • 其他的

第 10 章：PARP 抑制剂生物标记市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • PARP 抑制剂生物标记北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品）
    • 北美市场规模和预测（按服务）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • PARP 抑制剂生物标记欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按产品）
    • 欧洲市场规模和预测（按服务）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • PARP抑制剂生物标记物亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按产品）
    • 亚太地区市场规模与预测（按服务）
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • PARP 抑制剂生物标记拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品）
    • 拉丁美洲市场规模与预测（按服务）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • PARP 抑制剂生物标记物中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品）
    • 中东和非洲市场规模及预测（按服务）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - PARP 抑制剂生物标记产业

  • 竞争仪表板
  • 公司简介
    • Myriad Genetics, Inc.
    • CENTOGENE NV
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Agilent Technologies, Inc.
    • Amoy Diagnostics Co., Ltd.
    • Invitae Corporation
    • Ambry Genetics
    • NeoGenomics Laboratories.
    • QIAGEN.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3187

REPORT HIGHLIGHT

PARP Inhibitor Biomarkers Market size was valued at USD 915.8 Million in 2023, expanding at a CAGR of 8.80% from 2024 to 2032.

An agent that inhibits the cellular PARP enzyme. When DNA is broken, PARP aids in its repair. Numerous factors, including radiation, UV light exposure, some anticancer medications, and other compounds found in the environment, can harm DNA. In cancer treatment, PARP blocking may assist in preventing cancer cells from repairing their damaged DNA, which would ultimately lead to their demise. Known also as poly (ADP-ribose) polymerase inhibitors, PARP inhibitors are a class of targeted medicine.

PARP Inhibitor Biomarkers Market- Market Dynamics

Rising Costs for Cancer Management and Treatment to Propel Market Growth

Growing costs for the management and treatment of are anticipated to support market expansion. For instance, a journal paper from October 2022 in the Lancet Regional Health reported on treatment attrition and catastrophic costs for patients seeking full colorectal cancer therapy in India. Of the 226 patients that were included, four were lost to follow-up and 20 passed away within six months of receiving a treatment plan. Treatment for colorectal cancer cost, on average, 407,508 Indian Rupees (INR/5340 USD). The patient's PARP (median 330,277 INR/4328 USD) was the largest contributor to this total cost.

PARP Inhibitor Biomarkers Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.80 % over the forecast period (2024-2032)

Based on service segmentation, the BRCA 1 & 2 testing category was predicted to show maximum market share in the year 2023

Based on application segmentation, the breast cancer category was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

PARP Inhibitor Biomarkers Market- Segmentation Analysis:

The Global PARP Inhibitor Biomarkers Market is segmented on the basis of Product, Service, Application, and Region.

The market is divided into two categories based on product: Kits and Assays. The kits category dominates the market because these kits are used to test for and diagnose diseases associated with mutations and changes in genes. One of the most prevalent diseases linked to inherited DNA mutations is breast cancer. In order to address the growing demand for accurate and efficient diagnostics, major players in the market are continuously concentrating on developing new solutions. One FDA-approved test for determining individuals with advanced ovarian cancer who have a positive homologous recombination deficiency (HRD) status is myChoice CDx from Myriad Genetics, Inc.

The market is divided into the following categories based on application: Breast Cancer, Ovarian Cancer, and Others. The oncology category dominates the market and is likely to maintain its dominance during the forecast period. The increasing frequency of breast cancer linked to gene alterations brought on by BRCA1 or BRCA2 genetic mutations is thought to be the reason for the segment's expansion. The WHO article from February 2023 states that It is predicted that 2.5 million people would be affected by breast cancer by 2040. Breast cancer is the most common type of cancer in women and the main cause of cancer-related deaths in women in 95% of the world's countries. In spite of this, survival rates differ greatly, and the bulk of deaths take place in low- and middle-income nations. Over the past three decades, breast cancer mortality rates have significantly decreased in high-income countries, whereas low- and middle-income countries have not seen a comparable decline.

PARP Inhibitor Biomarkers Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for PARP inhibitor biomarkers. This high percentage can be attributed to rising cancer treatment costs, advances in genomic technologies, and rising cancer prevalence. An article from the American Cancer Society projects that in 2022, there will be about 609,360 cancer-related deaths and over 1.9 million new cancer cases diagnosed in the United States. As a result, as cancer is becoming more common, more patients are using genetic testing to identify potential candidates for PARP inhibitor therapy, which is driving up the cost of biomarker testing.

In addition, the PARP inhibitor biomarkers market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific ascribed to the existence of significant regional and national market participants including Thermo Fisher Scientific, Inc., QIAGEN, and Illumina, Inc. The region's growth is also expected to be fueled by government initiatives to improve healthcare infrastructure, a rise in per capita income that leads to a greater adoption of diagnostic and therapy products, and significantly increased investments in PARP inhibitor biomarkers technologies throughout the region. Over the course of the forecast period, emerging nations like China, Japan, and India are expected to fuel the market expansion due to the growing usage of smartphones with new advanced features.

PARP Inhibitor Biomarkers Market- Competitive Landscape:

Among the leading businesses in the field are Ambry Genetics, Myriad Genetics, Inc., Thermo Fisher Scientific, Inc., and Illumina, Inc. A highly concentrated market is indicated by the fact that a small group of producers have the majority of the market share. To counter the intense competition, these companies have turned to a variety of strategies, including partnerships, mergers and acquisitions, and the creation of new products.

Recent Developments:

February 2024: The genetic testing and precision medicine startup Myriad Genetics, Inc. has successfully acquired a number of assets from Intermountain Health's Intermountain Precision Genomics (IPG) laboratory group. The purchase includes his CLIA-certified laboratory in St. George, Utah, as well as Precision Fluid Testing and Precision Oncology Testing.

January 2024: ASCO and SSO guidelines about germline testing for breast cancer patients are something that Myriad Genetics, Inc., a manufacturer of genetic testing and precision medicine, has stated its support for. The business highlights the updating of the ASCO-SSO guidelines as a major step forward in the integration of genetics into patient treatment.

January 2023: Finding novel indicators for prostate cancer resistance to PARP medicines is made possible in large part by CRISPR technology. Researchers have used genome-wide CRISPR knockout screens to investigate the ways in which distinct genetic alterations affect PARP drug effectiveness. The identification of MMS22L, a gene that, when deleted, dramatically improves the sensitivity to PARP inhibitors, is a noteworthy finding from these investigations.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PARP INHIBITOR BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Myriad Genetics, Inc.

CENTOGENE N.V.

Thermo Fisher Scientific, Inc.

Illumina, Inc.

Agilent Technologies, Inc.

Amoy Diagnostics Co., Ltd.

Invitae Corporation

Ambry Genetics

NeoGenomics Laboratories.

QIAGEN

Others

GLOBAL PARP INHIBITOR BIOMARKERS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Kits
  • Assays

GLOBAL PARP INHIBITOR BIOMARKERS MARKET, BY SERVICE- MARKET ANALYSIS, 2019 - 2032

  • BRCA 1 & 2 Testing
  • HRD Testing
  • HRR Testing
  • Others

GLOBAL PARP INHIBITOR BIOMARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Breast Cancer
  • Ovarian Cancer
  • Others

GLOBAL PARP INHIBITOR BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. PARP Inhibitor Biomarkers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. PARP Inhibitor Biomarkers Market Snippet by Product
    • 2.1.2. PARP Inhibitor Biomarkers Market Snippet by Services
    • 2.1.3. PARP Inhibitor Biomarkers Market Snippet by Application
    • 2.1.4. PARP Inhibitor Biomarkers Market Snippet by Country
    • 2.1.5. PARP Inhibitor Biomarkers Market Snippet by Region
  • 2.2. Competitive Insights

3. PARP Inhibitor Biomarkers Key Market Trends

  • 3.1. PARP Inhibitor Biomarkers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. PARP Inhibitor Biomarkers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. PARP Inhibitor Biomarkers Market Opportunities
  • 3.4. PARP Inhibitor Biomarkers Market Future Trends

4. PARP Inhibitor Biomarkers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. PARP Inhibitor Biomarkers Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. PARP Inhibitor Biomarkers Market Landscape

  • 6.1. PARP Inhibitor Biomarkers Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. PARP Inhibitor Biomarkers Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Kits
    • 7.1.3. Assays

8. PARP Inhibitor Biomarkers Market - By Services

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Services, 2023 & 2032 (%)
    • 8.1.2. BRCA 1 & 2 Testing
    • 8.1.3. HRD Testing
    • 8.1.4. HRR Testing
    • 8.1.5. Others

9. PARP Inhibitor Biomarkers Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Breast Cancer
    • 9.1.3. Ovarian Cancer
    • 9.1.4. Others

10. PARP Inhibitor Biomarkers Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. PARP Inhibitor Biomarkers Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. PARP Inhibitor Biomarkers Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. PARP Inhibitor Biomarkers Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. PARP Inhibitor Biomarkers Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. PARP Inhibitor Biomarkers Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- PARP Inhibitor Biomarkers Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Myriad Genetics, Inc.
    • 11.2.2. CENTOGENE N.V.
    • 11.2.3. Thermo Fisher Scientific, Inc.
    • 11.2.4. Illumina, Inc.
    • 11.2.5. Agilent Technologies, Inc.
    • 11.2.6. Amoy Diagnostics Co., Ltd.
    • 11.2.7. Invitae Corporation
    • 11.2.8. Ambry Genetics
    • 11.2.9. NeoGenomics Laboratories.
    • 11.2.10. QIAGEN.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE PARP Inhibitor Biomarkers Market: Product Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global PARP Inhibitor Biomarkers Market, by Product 2019-2032 (USD Million)
  • TABLE PARP Inhibitor Biomarkers Market: Services Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Services
  • TABLE Global PARP Inhibitor Biomarkers Market, by Services 2019-2032 (USD Million)
  • TABLE PARP Inhibitor Biomarkers Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global PARP Inhibitor Biomarkers Market, by Application 2019-2032 (USD Million)
  • TABLE PARP Inhibitor Biomarkers Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global PARP Inhibitor Biomarkers Market, by Region 2019-2032 (USD Million)
  • TABLE North America PARP Inhibitor Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE North America PARP Inhibitor Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE North America PARP Inhibitor Biomarkers Market, by Services, 2019-2032 (USD Million)
  • TABLE North America PARP Inhibitor Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe PARP Inhibitor Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe PARP Inhibitor Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Europe PARP Inhibitor Biomarkers Market, by Services, 2019-2032 (USD Million)
  • TABLE Europe PARP Inhibitor Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific PARP Inhibitor Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific PARP Inhibitor Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Asia Pacific PARP Inhibitor Biomarkers Market, by Services, 2019-2032 (USD Million)
  • TABLE Asia Pacific PARP Inhibitor Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America PARP Inhibitor Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America PARP Inhibitor Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Latin America PARP Inhibitor Biomarkers Market, by Services, 2019-2032 (USD Million)
  • TABLE Latin America PARP Inhibitor Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PARP Inhibitor Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PARP Inhibitor Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PARP Inhibitor Biomarkers Market, by Services, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PARP Inhibitor Biomarkers Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE PARP Inhibitor Biomarkers Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product segment market share analysis, 2023 & 2032
  • FIGURE Product segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Services segment market share analysis, 2023 & 2032
  • FIGURE Services segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America PARP Inhibitor Biomarkers Market share and leading players, 2023
  • FIGURE Europe PARP Inhibitor Biomarkers Market share and leading players, 2023
  • FIGURE Asia Pacific PARP Inhibitor Biomarkers Market share and leading players, 2023
  • FIGURE Latin America PARP Inhibitor Biomarkers Market share and leading players, 2023
  • FIGURE Middle East and Africa PARP Inhibitor Biomarkers Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe PARP Inhibitor Biomarkers Market share analysis by country, 2023
  • FIGURE Germany PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific PARP Inhibitor Biomarkers Market share analysis by country, 2023
  • FIGURE India PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America PARP Inhibitor Biomarkers Market share analysis by country, 2023
  • FIGURE Brazil PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa PARP Inhibitor Biomarkers Market share analysis by country, 2023
  • FIGURE Saudi Arabia PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)